Characterization of a benzodiazepine receptor site with exceptionally high affinity for Ro 15-4513 in the rat CNS
- PMID: 8788925
- DOI: 10.1016/0006-8993(95)01133-1
Characterization of a benzodiazepine receptor site with exceptionally high affinity for Ro 15-4513 in the rat CNS
Abstract
The binding of [3H]Ro 15-4513, [3H]flunitrazepam and [3H]flumazenil to rat CNS membranes was studied at 2 degrees C, 22 degrees C and 37 degrees C using ligand concentrations ranging from approximately 0.06 nM to 10 microM. Analysis of the binding saturation data suggested the existence of high-affinity sites (Kd < 10 nM) and low-affinity sites (Kd > 100 nM) for each ligand. When binding was performed using very low ligand concentrations a benzodiazepine site with an exceptionally high affinity for Ro 15-4513 (Kd approximately 0.1 nM) was evident in all major regions of the CNS except the cerebellum. This site was most prevalent in the hippocampus, medulla and spinal cord where it accounted for approximately 70% of the specific binding when [3H]Ro 15-4513 was approximately 0.06 nM. The selectivity of Ro 15-4513 for this site as compared to other high-affinity sites was 20- to 60-fold depending on the incubation temperature and CNS region. The affinity for the very high-affinity site was decreased approximately 3-fold as temperature was increased from 2 degrees C to 37 degrees C (Kd approximately 0.1 nM and approximately 0.3, respectively), which was similar to the effect of temperature on other high-affinity sites (Kd approximately 2.6 nM at 2 degrees C and approximately 8 nM at 37 degrees C). Flumazenil, flunitrazepam, and diazepam did not differentiate the very high-affinity [3H]Ro 15-4513 site from other BZ sites, but alpidem exhibited a low affinity for it (IC50 approximately 5 microM). GABA at 100 microM had little effect on the Kd value for the very high-affinity site (GABA shift: approximately 0.8 to 1.0), suggesting that Ro 15-4513 is a partial inverse agonist or an antagonist at this site. These findings provide further evidence for the pharmacologic diversity of BZ sites on different subtypes of GABAA receptors.
Similar articles
-
Comparative autoradiographic distribution of central omega (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem.Brain Res. 1993 Feb 26;604(1-2):240-50. doi: 10.1016/0006-8993(93)90375-w. Brain Res. 1993. PMID: 8096157
-
Chronic benzodiazepine antagonist treatment and its withdrawal upregulates components of GABA-benzodiazepine receptor ionophore complex in cerebral cortex of rat.Brain Res. 1990 Jun 11;519(1-2):6-11. doi: 10.1016/0006-8993(90)90054-f. Brain Res. 1990. PMID: 2168788
-
Characterization of two cerebellar binding sites of [3H]Ro 15-4513.J Neurochem. 1992 Aug;59(2):568-74. doi: 10.1111/j.1471-4159.1992.tb09407.x. J Neurochem. 1992. PMID: 1321231
-
Do benzodiazepine ligands contribute to hepatic encephalopathy?Adv Exp Med Biol. 1993;341:57-69. doi: 10.1007/978-1-4615-2484-7_6. Adv Exp Med Biol. 1993. PMID: 8116487 Review.
-
Ethanol and the benzodiazepine-GABA receptor-ionophore complex.Experientia. 1989 May 15;45(5):413-8. doi: 10.1007/BF01952022. Experientia. 1989. PMID: 2542081 Review.
Cited by
-
Selective labelling of diazepam-insensitive GABAA receptors in vivo using [3H]Ro 15-4513.Br J Pharmacol. 2005 Nov;146(6):817-25. doi: 10.1038/sj.bjp.0706392. Br J Pharmacol. 2005. PMID: 16184188 Free PMC article.
-
The new low-toxic histone deacetylase inhibitor S-(2) induces apoptosis in various acute myeloid leukaemia cells.J Cell Mol Med. 2012 Aug;16(8):1758-65. doi: 10.1111/j.1582-4934.2011.01464.x. J Cell Mol Med. 2012. PMID: 22004558 Free PMC article.
-
Modulation of neurological pathways by Salvia officinalis and its dependence on manufacturing process and plant parts used.BMC Complement Altern Med. 2019 Jun 13;19(1):128. doi: 10.1186/s12906-019-2549-x. BMC Complement Altern Med. 2019. PMID: 31196061 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials